Retatrutide 40mg (R&D Only) – Advanced Research-Grade Peptide Pen

Retatrutide 40mg (R&D Only) is a high-purity research peptide supplied in a pre-filled Alluvi injection pen, designed exclusively for controlled laboratory and non-clinical research applications. Each pen provides a total of Retatrutide 40mg (R&D Only), enabling precise dosing for research studies, formulation analysis, and stability testing. The kit is strictly for laboratory use and not for human or veterinary consumption.

The pre-filled pen system ensures convenience and precision. Each full dose consists of 60 clicks (10mg), with 15 clicks equaling 2.5mg, making it easy to measure incremental doses accurately. This design supports repeatable, reliable experiments and eliminates the variability often associated with manual preparation of peptides.

🔹 Kit Contents

Each Retatrutide 40mg (R&D Only) research kit includes:

• 1 × Retatrutide 40mg (R&D Only) pre-filled injection pen

• Microfine needles for injection

• 1 × Information leaflet detailing handling, dosing, and storage

The pen’s advanced design ensures stability and precision for once-weekly dosing, making it an ideal tool for laboratory researchers studying dose response, peptide delivery, or compound stability.

🔹 How to Use Your Retatrutide 40mg (R&D Only) Pen

Step 1: Wash Your Hands
Clean your hands thoroughly with soap and water before handling the pen or needle to maintain a sterile environment.

Step 2: Prepare the Pen
Remove the pen cap and inspect the solution to ensure it is clear and free of particles. Select a new needle and remove the protective tab.

Step 3: Attach the Needle
Twist the needle firmly onto the pen to create a secure seal, preventing leakage and ensuring safe usage.

Step 4: Prime the Pen
Select a small test dose using the dose knob. Hold the pen upright and press the injection button to release any trapped air and ensure smooth flow.

Step 5: Select Your Dose
Use the dial to select the required dose. Confirm the correct measurement in the pen’s display window.

Dose by Clicks (Dial Setting):

• 15 clicks = 2.5mg

• 30 clicks = 5mg

• 45 clicks = 7.5mg

• 60 clicks = 10mg

Step 6: Choose an Injection Site
Recommended sites include the stomach (at least 2 inches from the belly button), thigh, or back of the upper arm. Rotate injection sites weekly to reduce skin irritation.

Step 7: Inject the Dose
Insert the needle at a 90-degree angle. Press the button fully and hold for 5–10 seconds to deliver the full dose. Remove the needle and dispose of it in a sharps container.

🔹 Recommended Research Dosing Plan

For structured studies, a gradual dosing plan is suggested to monitor responses accurately:

• Weeks 1–4: 2.5mg once weekly

• Weeks 5–8: 5mg once weekly

• Weeks 9–12: 7.5mg once weekly

• Weeks 13–18: 10mg once weekly

Adjustments can be made based on experimental observations, such as receptor activity or compound stability, allowing for controlled dose progression.

🔹 Storage & Handling for Retatrutide 40mg (R&D Only)

Before First Use:

• Refrigerate at 2–8°C

• Keep in original packaging

• Do not freeze

After First Use:

• Can be stored at room temperature (up to 30°C) for up to 4 hours

• Keep away from direct heat, sunlight, and moisture

• Always recap the pen and remove the needle

• Never store the pen with a needle attached

Proper storage ensures structural integrity, preventing degradation and maintaining accuracy for repeat experiments.

🔹 Tips for Best Use of Retatrutide 40mg (R&D Only)

• Prime the pen before first use

• Use a new needle for every injection

• Inject slowly and hold the button for full delivery

• Rotate injection sites to reduce irritation

• Log each dose and site for research tracking

• Dispose of used needles safely

🔹 Delivery & Support

• Dispatched with cold pack for temperature-controlled shipping

• Next-day tracked and signed delivery in the UK

• Questions or side effect reporting: info@alluvipharma.co.uk

This Retatrutide 40mg (R&D Only) pen provides a reliable, precision-engineered tool for laboratory studies, offering controlled dosing, stability, and consistency for all non-clinical research applications.